Organization
Radiation Oncology Key Laboratory of Sichuan Province
2 abstracts
Abstract
Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: A multicenter, randomized, parallel-controlled, phase II clinical trial.Org: Tianjin's Clinical Research Center for Cancer, Radiation Oncology Key Laboratory of Sichuan Province, University of Electronic Science and Technology of China, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University,
Abstract
Effect of FAPα-expressing tumor cell vaccine with PD-1 mAb on its efficacy in mice colorectal cancer model.Org: Sichuan Cancer hospital institute, Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan Province, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, School of Medicine, Zhejiang University, Hangzhou, China, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province,